Home > Compound List > Product Information
Potassium Chloride_Molecular_structure_CAS_7447-40-7)
Click picture or here to close

Potassium Chloride

Catalog No. DB00761 Name DrugBank
CAS Number 7447-40-7 Website http://www.ualberta.ca/
M. F. ClK Telephone (780) 492-3111
M. W. 74.5513 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 641

SYNONYMS

IUPAC name
potassium chloride
IUPAC Traditional name
potassium ion chloride
Brand Name
Repone-K
KCl
K-SR
Potasol
Enpott
Micro-K LS
Cena-K
K-Lyte/Cl
K-Sol
Kalinor-Retard P
Kalinorm
Kalitrans Retard
Kalium Retard
Kalium-R
Keylyte
Klotrix
Steropotassium
Chlorvescent
Durules-K
Emplets potassium chloride
K-Care
K-Contin
K-Grad
K. tab
KSR
Kaliolite
Kaon Ultra
Kay-Ciel
Kayback
Kelp salt
Micro-K Extentcaps
Neobakasal
Peter-kal
Pfiklor
Potasion
Rekawan Retard
Rum-K
Sal digestnum sylvii
Slow-K
Apo-K
Celeka
Chloropotassuril
Chloropotassuril diffu-K
Colyte
Duffi-K
Durekal
Durules
Enseal
Infalyte
K-Lyte Cl
K-Tab
K-lyte/C1
KCL Retard
KCl-retard Zyma
KM potassium chloride
Kalcorid
Kaleorid
Kaliglutol
Kalilente
Kalipoz
Kalium Duriles
Kalium S.R.
Kalium-duriles
Kaon CL
Kaon-Cl
Kato
Kay-cee-l
Klor-Con M20
Klor-Lyte
Leo K
Leo-K
Micro-Kalium Retard
Miopotasio
Potassium Chloride BP
Potassium muriate
Potavescent
Rekawan
Span-K
Super K
Trona muriate of potash
Trona potassium chloride
Ultra K Chlor
Acronitol
Addi-K
Clor-K-Zaf
Diffu-K
K Tab
K-Lease
K-Lor
K-Norm
K-Predne-dome
K-dur
Kadalex
Kaleorod
Kaliduron
Kalipor
Kalitabs
Kalium Durules
Kalium SR
Kalium-Durettes
Kaliumchlorid
Kaochlor
Kaon-ci
Kaskay
Kay Ciel
Kay-EM
Klor-Con
Kloren
Klorvess
Kolyum
Lento-K
Lento-kalium
Micro-K
Muriate of potash
Natural sylvite
Nu-K
Plus Kalium Retard
Potassium Chloride 10meq in Plastic Container
Repone K
Sando-K
Selora
Ten-K
Ultra-K-Chlor
Synonyms
Hydrochloric acid potassium salt (1:1)
Dipotassium dichloride
Tripotassium trichloride
Chloride of potash
Chlorid draselny [Czech]
ClK
Monopotassium chloride
Potassium thallium chloride (KTlCl)
Potassium monochloride

DATABASE IDS

CAS Number 7447-40-7
PubChem CID 4873
PubChem SID 46506038

PROPERTIES

Solubility Freely soluble

DETAILS

Description (English)
Item Information
Drug Groups approved; withdrawn
Description A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives.
Indication For use as an electrolyte replenisher and in the treatment of hypokalemia.
Pharmacology The potassium ion is in the principle intracellular cation of most body tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity, the transmission of nerve impulses, the contraction of cardiac, skeletal and smooth muscle, and the maintenance of normal renal function. The intracellular concentration of potassium is approximately 150 to 160 mEq per liter. The normal adult plasma concentration is 3.5 to 5 mEq per liter. An active ion transport system maintains this gradient across the plasma membrane. Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. The usual dietary intake of potassium is 50 to 100 mEq per day. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake. Such depletion usually develops as a consequence of therapy with diuretics, primarily or secondary hyperaldosteronism, diabetic ketoacidosis, or inadequate replacement of potassium in patients on prolonged parenteral nutrition. Depletion can develop rapidly with severe diarrhea, especially if associated with vomiting. Potassium depletion due to these causes is usually accompanied by concomitant loss of chloride and is manifested by hypokalemia and metabolic alkalosis. Potassium depletion may produce weakness, fatigue, disturbances of cardiac rhythm (primarily ectopic beats), prominent U-waves in the electrocardiogram, and, in advanced cases, flaccid paralysis and/or impaired ability to concentrate urine. If potassium depletion associated with metabolic alkalosis cannot be managed by correcting the fundamental cause of the deficiency, e.g., where the patient requires long-term diuretic therapy, supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels. In rare circumstances (e.g., patients with renal tubular acidosis) potassium depletion may be associated with metabolic acidosis and hyperchloremia. In such patients, potassium replacement should be accomplished with potassium salts other than the chloride, such as potassium bicarbonate, potassium citrate, potassium acetate, or potassium gluconate.
Toxicity The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, of if potassium is administered too rapidly intravenously, potentially fatal hyperkalemia can result. It is important to recognize that hyperkalemia is usually asymptomatic and may be manifested only by an increased serum potassium concentration (6.5-8.0 mEq/L) and characteristic electrocardiographic changes (peaking of T-waves, loss of P-wave, depression of S-T segment, and prolongation of the QT interval). Late manifestations include muscle paralysis and cardiovascular collapse from cardiac arrest (9-12 mEq/L).
Affected Organisms
Humans and other mammals
Absorption Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine.
Elimination Potassium is a normal dietary constituent and, under steady-state conditions, the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES